Market Overview

UPDATE: Imperial Capital Maintains on Brink's Company, Raises PT

Related BCO
Jim Cramer Advises His Viewers On CVS Health Corp And Brink's Company
Benzinga's Top Upgrades, Downgrades For August 9, 2017

In a report published Monday, Imperial Capital analyst Jeff Kessler maintained Outperform on Brink's Company (NYSE: BCO), raising its price target from $35.00 to $38.00.

According to the report, the analysts price target is based on comparative valuation of similar security companies. They do not rate the company's debt securities.

“During 3Q13, non-GAAP segment operating margin increased to 8.5% vs. 6.8% year-over-year (yoy), while international margin increased to 10.6% vs 7.6%, and North American margin decreased to 1.5% vs. 4.5%, on a non-GAAP basis,” the report said. “We continue to believe that Brink's can recover its North American operating margins to 5-6% over two years on the heels of 1) cost reductions, 2) increasing performing branches in the U.S., 3) changing the revenue mix, and 4) better results from strengthening the U.S. management team.”

The $38.00 price target is based on comparative valuation, the report noted.

BCO closed Friday at $34.13.

Latest Ratings for BCO

Aug 2017Imperial CapitalUpgradesIn-LineOutperform
Feb 2017SunTrust Robinson HumphreyInitiates Coverage OnBuy
Oct 2016Imperial CapitalDowngradesOutperformIn-Line

View More Analyst Ratings for BCO
View the Latest Analyst Ratings

Posted-In: imperial capital Jeff KesslerAnalyst Color Reiteration Analyst Ratings


Related Articles (BCO)

View Comments and Join the Discussion!

Partner Center